Mitochondria and reactive oxygen species: Physiology and pathophysiology

International Journal of Molecular Sciences

Volumn 14, Issue 3, 2013, Pages 6306-6344

  Bolisetty, Subhashini ^a   Jaimes, Edgar A ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Autophagy; Cell signaling; Hydrogen peroxide; Mitochondria; Mitochondria fission; Mitochondria fusion; Mitochondria network; Nitric oxide; Reactive oxygen species

Indexed keywords

ANTIOXIDANT; BILIRUBIN; CATALASE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2;

ANTIOXIDANT ACTIVITY; APOPTOSIS; AUTOPHAGY; CELL FUNCTION; CELL STRUCTURE; HOMEOSTASIS; HUMAN; MITOCHONDRION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

EID: 84875522423     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14036306     Document Type: Review

References (386)

1. Ernster, L.; Schatz, G. Mitochondria: A historical review. J. Cell Biol. 1981, 91, 227s-255s.
2. Gray, M.W.; Burger, G.; Lang, B.F. Mitochondrial evolution. Science 1999, 283, 1476-1481.
3. Hollenbeck, P.J.; Saxton, W.M. The axonal transport of mitochondria. J. Cell Sci. 2005, 118, 5411-5419.
4. Lenaz, G. The mitochondrial production of reactive oxygen species: Mechanisms and implications in human pathology. IUBMB Life 2001, 52, 159-164.
5. Swerdlow, R.H. Brain aging, Alzheimer's disease, and mitochondria. Biochim. Biophys. Acta 2011, 1812, 1630-1639.
6. Griffiths, E.J. Mitochondria and heart disease. Adv. Exp. Med. Biol. 2012, 942, 249-267.
7. Birch-Machin, M.A. Mitochondria and skin disease. Clin. Exp. Dermatol. 2000, 25, 141-146.
8. Frohman, M.A. Mitochondria as integrators of signal transduction and energy production in cardiac physiology and disease. J. Mol. Med. (Berl.) 2010, 88, 967-970.
9. Grattagliano, I.; Russmann, S.; Diogo, C.; Bonfrate, L.; Oliveira, P.J.; Wang, D.Q.; Portincasa, P. Mitochondria in chronic liver disease. Curr. Drug Targets 2011, 12, 879-893.
10. Duchen, M.R. Mitochondria in health and disease: Perspectives on a new mitochondrial biology. Mol. Aspects Med. 2004, 25, 365-451.
11. Smith, R.A.; Adlam, V.J.; Blaikie, F.H.; Manas, A.R.; Porteous, C.M.; James, A.M.; Ross, M.F.; Logan, A.; Cocheme, H.M.; Trnka, J.; et al. Mitochondria-targeted antioxidants in the treatment of disease. Ann. N. Y. Acad. Sci. 2008, 1147, 105-111.
12. Gobe, G.; Crane, D. Mitochondria, reactive oxygen species and cadmium toxicity in the kidney. Toxicol. Lett. 2010, 198, 49-55.
13. Cloonan, S.M.; Choi, A.M. Mitochondria: Commanders of innate immunity and disease? Curr. Opin. Immunol. 2012, 24, 32-40.
14. Nunnari, J.; Suomalainen, A. Mitochondria: In sickness and in health. Cell 2012, 148, 1145-1159.
15. Schapira, A.H. Mitochondrial diseases. Lancet 2012, 379, 1825-1834.
16. Armstrong, J.S. Mitochondrial medicine: Pharmacological targeting of mitochondria in disease. Br. J. Pharmacol. 2007, 151, 1154-1165.
17. Minocherhomji, S.; Tollefsbol, T.O.; Singh, K.K. Mitochondrial regulation of epigenetics and its role in human diseases. Epigenetics 2012, 7, 326-334.
18. Rocha, M.; Apostolova, N.; Hernandez-Mijares, A.; Herance, R.; Victor, V.M. Oxidative stress and endothelial dysfunction in cardiovascular disease: Mitochondria-targeted therapeutics. Curr. Med. Chem. 2010, 17, 3827-3841.
19. Diogo, C.V.; Grattagliano, I.; Oliveira, P.J.; Bonfrate, L.; Portincasa, P. Re-wiring the circuit: Mitochondria as a pharmacological target in liver disease. Curr. Med. Chem. 2011, 18, 5448-5465.
20. Johannsen, D.L.; Ravussin, E. The role of mitochondria in health and disease. Curr. Opin. Pharmacol. 2009, 9, 780-786.
21. Duchen, M.R. Roles of mitochondria in health and disease. Diabetes 2004, 53, S96-S102.
22. Duchen, M.R.; Szabadkai, G. Roles of mitochondria in human disease. Essays Biochem. 2010, 47, 115-137.
23. Hedskog, L.; Zhang, S.; Ankarcrona, M. Strategic role for mitochondria in Alzheimer's disease and cancer. Antioxid. Redox Signal. 2012, 16, 1476-1491.
24. Watson, K.; Haslam, J.M.; Linnane, A.W. Biogenesis of mitochondria. 13. The isolation of mitochondrial structures from anaerobically grown Saccharomyces cerevisiae. J. Cell Biol. 1970, 46, 88-96.
25. Green, D.E.; Oda, T. On the unit of mitochondrial structure and function. J. Biochem. 1961, 49, 742-757.
26. Neupert, W. Protein import into mitochondria. Annu. Rev. Biochem. 1997, 66, 863-917.
27. Pfanner, N.; Craig, E.A.; Honlinger, A. Mitochondrial preprotein translocase. Annu. Rev. Cell Dev. Biol. 1997, 13, 25-51.
28. Dekker, P.J.; Ryan, M.T.; Brix, J.; Muller, H.; Honlinger, A.; Pfanner, N. Preprotein translocase of the outer mitochondrial membrane: Molecular dissection and assembly of the general import pore complex. Mol. Cell. Biol. 1998, 18, 6515-6524.
29. Yamamoto, H.; Itoh, N.; Kawano, S.; Yatsukawa, Y.; Momose, T.; Makio, T.; Matsunaga, M.; Yokota, M.; Esaki, M.; Shodai, T.; et al. Dual role of the receptor Tom20 in specificity and efficiency of protein import into mitochondria. Proc. Natl. Acad. Sci. USA 2011, 108, 91-96.
30. Herrmann, J.M.; Riemer, J. The intermembrane space of mitochondria. Antioxid. Redox Signal. 2010, 13, 1341-1358.
31. Davies, K.M.; Strauss, M.; Daum, B.; Kief, J.H.; Osiewacz, H.D.; Rycovska, A.; Zickermann, V.; Kuhlbrandt, W. Macromolecular organization of ATP synthase and complex I in whole mitochondria. Proc. Natl. Acad. Sci. USA 2011, 108, 14121-14126.
32. O'Rourke, B. Mitochondrial ion channels. Annu. Rev. Physiol. 2007, 69, 19-49.
33. Asin-Cayuela, J.; Gustafsson, C.M. Mitochondrial transcription and its regulation in mammalian cells. Trends Biochem. Sci. 2007, 32, 111-117.
34. Halliwell, B.; Gutteridge, J.M. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 1984, 219, 1-14.
35. Cline, M.J.; Lehrer, R.I. D-amino acid oxidase in leukocytes: A possible D-amino-acid-linked antimicrobial system. Proc. Natl. Acad. Sci. USA 1969, 62, 756-763.
36. Ji, L.L. Antioxidant signaling in skeletal muscle: A brief review. Exp. Gerontol. 2007, 42, 582-593.
37. Kim, C.; Kim, J.Y.; Kim, J.H. Cytosolic phospholipase A2, lipoxygenase metabolites, and reactive oxygen species. BMB Rep. 2008, 41, 555-559.
38. Nishino, T. The conversion of xanthine dehydrogenase to xanthine oxidase and the role of the enzyme in reperfusion injury. J. Biochem. 1994, 116, 1-6.
39. Nishino, T.; Okamoto, K.; Eger, B.T.; Pai, E.F. Mammalian xanthine oxidoreductase-Mechanism of transition from xanthine dehydrogenase to xanthine oxidase. FEBS J. 2008, 275, 3278-3289.
40. Sumimoto, H.; Miyano, K.; Takeya, R. Molecular composition and regulation of the Nox family NAD(P)H oxidases. Biochem. Biophys. Res. Commun. 2005, 338, 677-686.
41. Zangar, R.C.; Davydov, D.R.; Verma, S. Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol. Appl. Pharmacol. 2004, 199, 316-331.
42. Brown, G.C. Control of respiration and ATP synthesis in mammalian mitochondria and cells. Biochem. J. 1992, 284, 1-13.
43. Paul, T. Effect of a prolonged superoxide flux on transferrin and ferritin. Arch. Biochem. Biophys. 2000, 382, 253-261.
44. Biemond, P.; Swaak, A.J.; van Eijk, H.G.; Koster, J.F. Superoxide dependent iron release from ferritin in inflammatory diseases. Free Radic. Biol. Med. 1988, 4, 185-198.
45. Liochev, S.L. The role of iron-sulfur clusters in in vivo hydroxyl radical production. Free Radic. Res. 1996, 25, 369-384.
46. Flint, D.H.; Tuminello, J.F.; Emptage, M.H. The inactivation of Fe-S cluster containing hydro-lyases by superoxide. J. Biol. Chem. 1993, 268, 22369-22376.
47. Lenaz, G. Mitochondria and reactive oxygen species. Which role in physiology and pathology? Adv. Exp. Med. Biol. 2012, 942, 93-136.
48. McLennan, H.R.; Esposti, M.D. The contribution of mitochondrial respiratory complexes to the production of reactive oxygen species. J. Bioenerg. Biomembr. 2000, 32, 153-162.
49. Fato, R.; Bergamini, C.; Leoni, S.; Strocchi, P.; Lenaz, G. Generation of reactive oxygen species by mitochondrial complex I: Implications in neurodegeneration. Neurochem. Res. 2008, 33, 2487-2501.
50. Murphy, M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417, 1-13.
51. Yankovskaya, V.; Horsefield, R.; Tornroth, S.; Luna-Chavez, C.; Miyoshi, H.; Leger, C.; Byrne, B.; Cecchini, G.; Iwata, S. Architecture of succinate dehydrogenase and reactive oxygen species generation. Science 2003, 299, 700-704.
52. Casteilla, L.; Rigoulet, M.; Penicaud, L. Mitochondrial ROS metabolism: Modulation by uncoupling proteins. IUBMB Life 2001, 52, 181-188.
53. 2 production from mitochondrial respiratory chain. Biochem. Biophys. Res. Commun. 2001, 281, 645-650.
54. Barja, G. Mitochondrial oxygen radical generation and leak: Sites of production in states 4 and 3, organ specificity, and relation to aging and longevity. J. Bioenerg. Biomembr. 1999, 31, 347-366.
55. + oxidation-reduction state. Biochem. J. 2002, 368, 545-553.
56. Barja, G.; Herrero, A. Localization at complex I and mechanism of the higher free radical production of brain nonsynaptic mitochondria in the short-lived rat than in the longevous pigeon. J. Bioenerg. Biomembr. 1998, 30, 235-243.
57. Turrens, J.F.; Boveris, A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 1980, 191, 421-427.
58. Miwa, S.; St-Pierre, J.; Partridge, L.; Brand, M.D. Superoxide and hydrogen peroxide production by Drosophila mitochondria. Free Radic. Biol. Med. 2003, 35, 938-948.
59. Drahota, Z.; Chowdhury, S.K.; Floryk, D.; Mracek, T.; Wilhelm, J.; Rauchova, H.; Lenaz, G.; Houstek, J. Glycerophosphate-dependent hydrogen peroxide production by brown adipose tissue mitochondria and its activation by ferricyanide. J. Bioenerg. Biomembr. 2002, 34, 105-113.
60. 2 emission during long-chain fatty acid oxidation. J. Biol. Chem. 2010, 285, 5748-5758.
61. Maurel, A.; Hernandez, C.; Kunduzova, O.; Bompart, G.; Cambon, C.; Parini, A.; Frances, B. Age-dependent increase in hydrogen peroxide production by cardiac monoamine oxidase A in rats. Am. J. Physiol. Heart Circ. Physiol. 2003, 284, H1460-H1467.
62. Starkov, A.A.; Fiskum, G.; Chinopoulos, C.; Lorenzo, B.J.; Browne, S.E.; Patel, M.S.; Beal, M.F. Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J. Neurosci. 2004, 24, 7779-7788.
63. Tretter, L.; Adam-Vizi, V. Generation of reactive oxygen species in the reaction catalyzed by alpha-ketoglutarate dehydrogenase. J. Neurosci. 2004, 24, 7771-7778.
64. MacMillan-Crow, L.A.; Crow, J.P.; Thompson, J.A. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry 1998, 37, 1613-1622.
65. Lacza, Z.; Snipes, J.A.; Zhang, J.; Horvath, E.M.; Figueroa, J.P.; Szabo, C.; Busija, D.W. Mitochondrial nitric oxide synthase is not eNOS, nNOS or iNOS. Free Radic. Biol. Med. 2003, 35, 1217-1228.
66. Ghafourifar, P.; Richter, C. Nitric oxide synthase activity in mitochondria. FEBS Lett. 1997, 418, 291-296.
67. Giulivi, C.; Poderoso, J.J.; Boveris, A. Production of nitric oxide by mitochondria. J. Biol. Chem. 1998, 273, 11038-11043.
68. Alvarez, S.; Valdez, L.B.; Zaobornyj, T.; Boveris, A. Oxygen dependence of mitochondrial nitric oxide synthase activity. Biochem. Biophys. Res. Commun. 2003, 305, 771-775.
69. Lacza, Z.; Puskar, M.; Figueroa, J.P.; Zhang, J.; Rajapakse, N.; Busija, D.W. Mitochondrial nitric oxide synthase is constitutively active and is functionally upregulated in hypoxia. Free Radic. Biol. Med. 2001, 31, 1609-1615.
70. Bates, T.E.; Loesch, A.; Burnstock, G.; Clark, J.B. Immunocytochemical evidence for a mitochondrially located nitric oxide synthase in brain and liver. Biochem. Biophys. Res. Commun. 1995, 213, 896-900.
71. Haynes, V.; Elfering, S.; Traaseth, N.; Giulivi, C. Mitochondrial nitric-oxide synthase: Enzyme expression, characterization, and regulation. J. Bioenerg. Biomembr. 2004, 36, 341-346.
72. Giulivi, C. Mitochondria as generators and targets of nitric oxide. Novartis Found. Symp. 2007, 287, 92-100; discussion 100-104.
73. Lacza, Z.; Kozlov, A.V.; Pankotai, E.; Csordas, A.; Wolf, G.; Redl, H.; Kollai, M.; Szabo, C.; Busija, D.W.; Horn, T.F. Mitochondria produce reactive nitrogen species via an arginine-independent pathway. Free Radic. Res. 2006, 40, 369-378.
74. Kozlov, A.V.; Staniek, K.; Nohl, H. Nitrite reductase activity is a novel function of mammalian mitochondria. FEBS Lett. 1999, 454, 127-130.
75. Lacza, Z.; Pankotai, E.; Csordas, A.; Gero, D.; Kiss, L.; Horvath, E.M.; Kollai, M.; Busija, D.W.; Szabo, C. Mitochondrial NO and reactive nitrogen species production: Does mtNOS exist? Nitric. Oxide 2006, 14, 162-168.
76. Mason, M.G.; Nicholls, P.; Wilson, M.T.; Cooper, C.E. Nitric oxide inhibition of respiration involves both competitive (heme) and noncompetitive (copper) binding to cytochrome c oxidase. Proc. Natl. Acad. Sci. USA 2006, 103, 708-713.
77. Cooper, C.E.; Giulivi, C. Nitric oxide regulation of mitochondrial oxygen consumption II: Molecular mechanism and tissue physiology. Am. J. Physiol. Cell Physiol. 2007, 292, C1993-C2003.
78. Gladwin, M.T.; Shiva, S. The ligand binding battle at cytochrome c oxidase: How NO regulates oxygen gradients in tissue. Circ. Res. 2009, 104, 1136-1138.
79. Brunori, M.; Forte, E.; Arese, M.; Mastronicola, D.; Giuffre, A.; Sarti, P. Nitric oxide and the respiratory enzyme. Biochim. Biophys. Acta 2006, 1757, 1144-1154.
80. Sarti, P.; Forte, E.; Giuffre, A.; Mastronicola, D.; Magnifico, M.C.; Arese, M. The chemical interplay between nitric oxide and mitochondrial cytochrome c oxidase: Reactions, effectors and pathophysiology. Int. J. Cell Biol. 2012, 2012, 571067.
81. Poderoso, J.J.; Carreras, M.C.; Lisdero, C.; Riobo, N.; Schopfer, F.; Boveris, A. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch. Biochem. Biophys. 1996, 328, 85-92.
82. Brown, G.C.; Borutaite, V. Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols. Biochim. Biophys. Acta 2004, 1658, 44-49.
83. Nisoli, E.; Falcone, S.; Tonello, C.; Cozzi, V.; Palomba, L.; Fiorani, M.; Pisconti, A.; Brunelli, S.; Cardile, A.; Francolini, M.; et al. Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc. Natl. Acad. Sci. USA 2004, 101, 16507-16512.
84. Shen, W.; Hintze, T.H.; Wolin, M.S. Nitric oxide. An important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation 1995, 92, 3505-3512.
85. Brown, G.C. Nitric oxide and mitochondrial respiration. Biochim. Biophys. Acta 1999, 1411, 351-369.
86. Nisoli, E.; Clementi, E.; Paolucci, C.; Cozzi, V.; Tonello, C.; Sciorati, C.; Bracale, R.; Valerio, A.; Francolini, M.; Moncada, S.; et al. Mitochondrial biogenesis in mammals: The role of endogenous nitric oxide. Science 2003, 299, 896-899.
87. Xie, Y.W.; Kaminski, P.M.; Wolin, M.S. Inhibition of rat cardiac muscle contraction and mitochondrial respiration by endogenous peroxynitrite formation during posthypoxic reoxygenation. Circ. Res. 1998, 82, 891-897.
88. Radi, R.; Rodriguez, M.; Castro, L.; Telleri, R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch. Biochem. Biophys. 1994, 308, 89-95.
89. Piantadosi, C.A.; Suliman, H.B. Redox regulation of mitochondrial biogenesis. Free Radic. Biol. Med. 2012, 53, 2043-2053.
90. Bourens, M.; Fontanesi, F.; Soto, I.C.; Liu, J.; Barrientos, A. Redox and reactive oxygen species regulation of mitochondrial cytochrome c oxidase biogenesis. Antioxid. Redox Signal. 2012, doi:10.1089/ars.2012.4847.
91. Nisoli, E.; Tonello, C.; Cardile, A.; Cozzi, V.; Bracale, R.; Tedesco, L.; Falcone, S.; Valerio, A.; Cantoni, O.; Clementi, E.; et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 2005, 310, 314-317.
92. Nisoli, E.; Clementi, E.; Moncada, S.; Carruba, M.O. Mitochondrial biogenesis as a cellular signaling framework. Biochem. Pharmacol. 2004, 67, 1-15.
93. Lee, H.C.; Wei, Y.H. Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int. J. Biochem. Cell Biol. 2005, 37, 822-834.
94. Kong, X.; Wang, R.; Xue, Y.; Liu, X.; Zhang, H.; Chen, Y.; Fang, F.; Chang, Y. Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One 2010, 5, e11707.
95. Piantadosi, C.A.; Carraway, M.S.; Haden, D.W.; Suliman, H.B. Protecting the permeability pore and mitochondrial biogenesis. Novartis Found. Symp. 2007, 280, 266-276; discussion 276-280.
96. Handy, D.E.; Loscalzo, J. Redox regulation of mitochondrial function. Antioxid. Redox Signal. 2012, 16, 1323-1367.
97. Le Bras, M.; Clement, M.V.; Pervaiz, S.; Brenner, C. Reactive oxygen species and the mitochondrial signaling pathway of cell death. Histol. Histopathol. 2005, 20, 205-219.
98. Ma, Z.A. The role of peroxidation of mitochondrial membrane phospholipids in pancreatic beta-cell failure. Curr. Diabetes Rev. 2012, 8, 69-75.
99. Mizushima, N.; Levine, B.; Cuervo, A.M.; Klionsky, D.J. Autophagy fights disease through cellular self-digestion. Nature 2008, 451, 1069-1075.
100. Mizushima, N. Autophagy: Process and function. Genes Dev. 2007, 21, 2861-2873.
101. Kiffin, R.; Bandyopadhyay, U.; Cuervo, A.M. Oxidative stress and autophagy. Antioxid. Redox Signal. 2006, 8, 152-162.
102. Mizushima, N.; Klionsky, D.J. Protein turnover via autophagy: Implications for metabolism. Annu. Rev. Nutr. 2007, 27, 19-40.
103. Nakatogawa, H.; Suzuki, K.; Kamada, Y.; Ohsumi, Y. Dynamics and diversity in autophagy mechanisms: Lessons from yeast. Nat. Rev. Mol. Cell Biol. 2009, 10, 458-467.
104. Klionsky, D.J.; Cregg, J.M.; Dunn, W.A., Jr.; Emr, S.D.; Sakai, Y.; Sandoval, I.V.; Sibirny, A.; Subramani, S.; Thumm, M.; Veenhuis, M.; et al. A unified nomenclature for yeast autophagy-related genes. Dev. Cell 2003, 5, 539-545.
105. Levine, B.; Mizushima, N.; Virgin, H.W. Autophagy in immunity and inflammation. Nature 2011, 469, 323-335.
106. Azad, M.B.; Chen, Y.; Gibson, S.B. Regulation of autophagy by reactive oxygen species (ROS): Implications for cancer progression and treatment. Antioxid. Redox Signal. 2009, 11, 777-790.
107. Scherz-Shouval, R.; Shvets, E.; Fass, E.; Shorer, H.; Gil, L.; Elazar, Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J. 2007, 26, 1749-1760.
108. Mathew, R.; White, E. Autophagy, stress, and cancer metabolism: What doesn't kill you makes you stronger. Cold Spring Harb. Symp. Quant. Biol. 2011, 76, 389-396.
109. Li, Z.Y.; Yang, Y.; Ming, M.; Liu, B. Mitochondrial ROS generation for regulation of autophagic pathways in cancer. Biochem. Biophys. Res. Commun. 2011, 414, 5-8.
110. Ishdorj, G.; Li, L.; Gibson, S.B. Regulation of autophagy in hematological malignancies: Role of reactive oxygen species. Leuk Lymphoma 2012, 53, 26-33.
111. Yu, L.; Alva, A.; Su, H.; Dutt, P.; Freundt, E.; Welsh, S.; Baehrecke, E.H.; Lenardo, M.J. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004, 304, 1500-1502.
112. Reef, S.; Zalckvar, E.; Shifman, O.; Bialik, S.; Sabanay, H.; Oren, M.; Kimchi, A. A short mitochondrial form of p19ARF induces autophagy and caspase-independent cell death. Mol. Cell 2006, 22, 463-475.
113. Cuervo, A.M. Autophagy and aging-When "all you can eat" is yourself. Sci. Aging Knowl. Environ. 2003, 2003, 25.
114. Codogno, P.; Meijer, A.J. Autophagy and signaling: Their role in cell survival and cell death. Cell Death Differ. 2005, 12, 1509-1518.
115. Yuan, H.; Perry, C.N.; Huang, C.; Iwai-Kanai, E.; Carreira, R.S.; Glembotski, C.C.; Gottlieb, R.A. LPS-induced autophagy is mediated by oxidative signaling in cardiomyocytes and is associated with cytoprotection. Am. J. Physiol. Heart Circ. Physiol. 2009, 296, H470-H479.
116. Chen, Y.; McMillan-Ward, E.; Kong, J.; Israels, S.J.; Gibson, S.B. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death Differ. 2008, 15, 171-182.
117. Chen, Y.; McMillan-Ward, E.; Kong, J.; Israels, S.J.; Gibson, S.B. Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species. J. Cell Sci. 2007, 120, 4155-4166.
118. Chen, Y.; Azad, M.B.; Gibson, S.B. Superoxide is the major reactive oxygen species regulating autophagy. Cell Death Differ. 2009, 16, 1040-1052.
119. Yang, J.; Wu, L.J.; Tashino, S.; Onodera, S.; Ikejima, T. Reactive oxygen species and nitric oxide regulate mitochondria-dependent apoptosis and autophagy in evodiamine-treated human cervix carcinoma HeLa cells. Free Radic. Res. 2008, 42, 492-504.
120. Bolisetty, S.; Traylor, A.M.; Kim, J.; Joseph, R.; Ricart, K.; Landar, A.; Agarwal, A. Heme oxygenase-1 inhibits renal tubular macroautophagy in acute kidney injury. J. Am. Soc. Nephrol. 2010, 21, 1702-1712.
121. Morse, D.; Lin, L.; Choi, A.M.; Ryter, S.W. Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and disease. Free Radic. Biol. Med. 2009, 47, 1-12.
122. Byun, Y.J.; Kim, S.K.; Kim, Y.M.; Chae, G.T.; Jeong, S.W.; Lee, S.B. Hydrogen peroxide induces autophagic cell death in C6 glioma cells via BNIP3-mediated suppression of the mTOR pathway. Neurosci. Lett. 2009, 461, 131-135.
123. Zhang, H.; Kong, X.; Kang, J.; Su, J.; Li, Y.; Zhong, J.; Sun, L. Oxidative stress induces parallel autophagy and mitochondria dysfunction in human glioma U251 cells. Toxicol. Sci. 2009, 110, 376-388.
124. McClung, J.M.; Judge, A.R.; Powers, S.K.; Yan, Z. p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting. Am. J. Physiol. Cell Physiol. 2010, 298, C542-549.
125. Wong, C.H.; Iskandar, K.B.; Yadav, S.K.; Hirpara, J.L.; Loh, T.; Pervaiz, S. Simultaneous induction of non-canonical autophagy and apoptosis in cancer cells by ROS-dependent ERK and JNK activation. PLoS One 2010, 5, e9996.
126. Wang, S.H.; Shih, Y.L.; Kuo, T.C.; Ko, W.C.; Shih, C.M. Cadmium toxicity toward autophagy through ROS-activated GSK-3beta in mesangial cells. Toxicol. Sci. 2009, 108, 124-131.
127. Huang, J.; Canadien, V.; Lam, G.Y.; Steinberg, B.E.; Dinauer, M.C.; Magalhaes, M.A.; Glogauer, M.; Grinstein, S.; Brumell, J.H. Activation of antibacterial autophagy by NADPH oxidases. Proc. Natl. Acad. Sci. USA 2009, 106, 6226-6231.
128. Mitroulis, I.; Kourtzelis, I.; Kambas, K.; Rafail, S.; Chrysanthopoulou, A.; Speletas, M.; Ritis, K. Regulation of the autophagic machinery in human neutrophils. Eur. J. Immunol. 2010, 40, 1461-1472.
129. Huang, J.; Brumell, J.H. NADPH oxidases contribute to autophagy regulation. Autophagy 2009, 5, 887-889.
130. Sanjuan, M.A.; Dillon, C.P.; Tait, S.W.; Moshiach, S.; Dorsey, F.; Connell, S.; Komatsu, M.; Tanaka, K.; Cleveland, J.L.; Withoff, S.; et al. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 2007, 450, 1253-1257.
131. Kissova, I.; Deffieu, M.; Manon, S.; Camougrand, N. Uth1p is involved in the autophagic degradation of mitochondria. J. Biol. Chem. 2004, 279, 39068-39074.
132. Lemasters, J.J. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res. 2005, 8, 3-5.
133. Narendra, D.P.; Jin, S.M.; Tanaka, A.; Suen, D.F.; Gautier, C.A.; Shen, J.; Cookson, M.R.; Youle, R.J. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 2010, 8, e1000298.
134. Jin, S.M.; Lazarou, M.; Wang, C.; Kane, L.A.; Narendra, D.P.; Youle, R.J. Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J. Cell Biol. 2010, 191, 933-942.
135. Narendra, D.; Tanaka, A.; Suen, D.F.; Youle, R.J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 2008, 183, 795-803.
136. Vives-Bauza, C.; Zhou, C.; Huang, Y.; Cui, M.; de Vries, R.L.; Kim, J.; May, J.; Tocilescu, M.A.; Liu, W.; Ko, H.S.; et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc. Natl. Acad. Sci. USA 2010, 107, 378-383.
137. Matsuda, N.; Sato, S.; Shiba, K.; Okatsu, K.; Saisho, K.; Gautier, C.A.; Sou, Y.S.; Saiki, S.; Kawajiri, S.; Sato, F.; et al. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J. Cell Biol. 2010, 189, 211-221.
138. Geisler, S.; Holmstrom, K.M.; Skujat, D.; Fiesel, F.C.; Rothfuss, O.C.; Kahle, P.J.; Springer, W. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol. 2010, 12, 119-131.
139. Egan, D.F.; Shackelford, D.B.; Mihaylova, M.M.; Gelino, S.; Kohnz, R.A.; Mair, W.; Vasquez, D.S.; Joshi, A.; Gwinn, D.M.; Taylor, R.; et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 2011, 331, 456-461.
140. Nishida, K.; Yamaguchi, O.; Otsu, K. Crosstalk between autophagy and apoptosis in heart disease. Circ. Res. 2008, 103, 343-351.
141. Youle, R.J.;van der Bliek, A.M. Mitochondrial fission, fusion, and stress. Science 2012, 337, 1062-1065.
142. Benard, G.; Karbowski, M. Mitochondrial fusion and division: Regulation and role in cell viability. Semin. Cell Dev. Biol. 2009, 20, 365-374.
143. Pletjushkina, O.Y.; Lyamzaev, K.G.; Popova, E.N.; Nepryakhina, O.K.; Ivanova, O.Y.; Domnina, L.V.; Chernyak, B.V.; Skulachev, V.P. Effect of oxidative stress on dynamics of mitochondrial reticulum. Biochim. Biophys. Acta 2006, 1757, 518-524.
144. 2-induced mitochondrial fragmentation in C2C12 myocytes. Free Radic. Biol. Med. 2010, 49, 1646-1654.
145. Jendrach, M.; Mai, S.; Pohl, S.; Voth, M.; Bereiter-Hahn, J. Short-and long-term alterations of mitochondrial morphology, dynamics and mtDNA after transient oxidative stress. Mitochondrion 2008, 8, 293-304.
146. Makino, A.; Scott, B.T.; Dillmann, W.H. Mitochondrial fragmentation and superoxide anion production in coronary endothelial cells from a mouse model of type 1 diabetes. Diabetologia 2010, 53, 1783-1794.
147. Barsoum, M.J.; Yuan, H.; Gerencser, A.A.; Liot, G.; Kushnareva, Y.; Graber, S.; Kovacs, I.; Lee, W.D.; Waggoner, J.; Cui, J.; et al. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J. 2006, 25, 3900-3911.
148. Liot, G.; Bossy, B.; Lubitz, S.; Kushnareva, Y.; Sejbuk, N.; Bossy-Wetzel, E. Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA-and ROS-dependent pathway. Cell Death Differ. 2009, 16, 899-909.
149. Brooks, C.; Wei, Q.; Cho, S.G.; Dong, Z. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J. Clin. Invest. 2009, 119, 1275-1285.
150. Funk, J.A.; Schnellmann, R.G. Persistent disruption of mitochondrial homeostasis after acute kidney injury. Am. J. Physiol. Renal Physiol. 2012, 302, F853-F864.
151. Yu, T.; Sheu, S.S.; Robotham, J.L.; Yoon, Y. Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species. Cardiovasc. Res. 2008, 79, 341-351.
152. Giedt, R.J.; Yang, C.; Zweier, J.L.; Matzavinos, A.; Alevriadou, B.R. Mitochondrial fission in endothelial cells after simulated ischemia/reperfusion: Role of nitric oxide and reactive oxygen species. Free Radic. Biol. Med. 2012, 52, 348-356.
153. Solesio, M.E.; Prime, T.A.; Logan, A.; Murphy, M.P.; Del Mar Arroyo-Jimenez, M.; Jordan, J.; Galindo, M.F. The mitochondria-targeted anti-oxidant MitoQ reduces aspects of mitochondrial fission in the 6-OHDA cell model of Parkinson's disease. Biochim. Biophys. Acta 2012, 1832, 174-182.
154. Estaquier, J.; Arnoult, D. Inhibiting Drp1-mediated mitochondrial fission selectively prevents the release of cytochrome c during apoptosis. Cell Death Differ. 2007, 14, 1086-1094.
155. Frank, S.; Gaume, B.; Bergmann-Leitner, E.S.; Leitner, W.W.; Robert, E.G.; Catez, F.; Smith, C.L.; Youle, R.J. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev. Cell 2001, 1, 515-525.
156. Lee, Y.J.; Jeong, S.Y.; Karbowski, M.; Smith, C.L.; Youle, R.J. Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol. Biol. Cell 2004, 15, 5001-5011.
157. Sugioka, R.; Shimizu, S.; Tsujimoto, Y. Fzo1, a protein involved in mitochondrial fusion, inhibits apoptosis. J. Biol. Chem. 2004, 279, 52726-52734.
158. James, D.I.; Parone, P.A.; Mattenberger, Y.; Martinou, J.C. hFis1, a novel component of the mammalian mitochondrial fission machinery. J. Biol. Chem. 2003, 278, 36373-36379.
159. Olichon, A.; Baricault, L.; Gas, N.; Guillou, E.; Valette, A.; Belenguer, P.; Lenaers, G. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J. Biol. Chem. 2003, 278, 7743-7746.
160. Parone, P.A.; Da Cruz, S.; Tondera, D.; Mattenberger, Y.; James, D.I.; Maechler, P.; Barja, F.; Martinou, J.C. Preventing mitochondrial fission impairs mitochondrial function and leads to loss of mitochondrial DNA. PLoS One 2008, 3, e3257.
161. Benard, G.; Bellance, N.; James, D.; Parrone, P.; Fernandez, H.; Letellier, T.; Rossignol, R. Mitochondrial bioenergetics and structural network organization. J. Cell Sci. 2007, 120, 838-848.
162. Frank, M.; Duvezin-Caubet, S.; Koob, S.; Occhipinti, A.; Jagasia, R.; Petcherski, A.; Ruonala, M.O.; Priault, M.; Salin, B.; Reichert, A.S. Mitophagy is triggered by mild oxidative stress in a mitochondrial fission dependent manner. Biochim. Biophys. Acta 2012, 1823, 2297-2310.
163. Park, J.; Lee, J.; Choi, C. Mitochondrial network determines intracellular ROS dynamics and sensitivity to oxidative stress through switching inter-mitochondrial messengers. PLoS One 2011, 6, e23211.
164. Jou, M.J. Pathophysiological and pharmacological implications of mitochondria-targeted reactive oxygen species generation in astrocytes. Adv. Drug Deliv. Rev. 2008, 60, 1512-1526.
165. Yoon, Y.; Galloway, C.A.; Jhun, B.S.; Yu, T. Mitochondrial dynamics in diabetes. Antioxid. Redox Signal. 2011, 14, 439-457.
166. Duncan, J.G. Mitochondrial dysfunction in diabetic cardiomyopathy. Biochim. Biophys. Acta 2011, 1813, 1351-1359.
167. Ong, S.B.; Hausenloy, D.J. Mitochondrial morphology and cardiovascular disease. Cardiovasc. Res. 2010, 88, 16-29.
168. Romanello, V.; Guadagnin, E.; Gomes, L.; Roder, I.; Sandri, C.; Petersen, Y.; Milan, G.; Masiero, E.; del Piccolo, P.; Foretz, M.; et al. Mitochondrial fission and remodelling contributes to muscle atrophy. EMBO J. 2010, 29, 1774-1785.
169. Ong, S.B.; Subrayan, S.; Lim, S.Y.; Yellon, D.M.; Davidson, S.M.; Hausenloy, D.J. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 2010, 121, 2012-2022.
170. Chen, L.; Gong, Q.; Stice, J.P.; Knowlton, A.A. Mitochondrial OPA1, apoptosis, and heart failure. Cardiovasc. Res. 2009, 84, 91-99.
171. Nakamura, K.; Nemani, V.M.; Azarbal, F.; Skibinski, G.; Levy, J.M.; Egami, K.; Munishkina, L.; Zhang, J.; Gardner, B.; Wakabayashi, J.; et al. Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J. Biol. Chem. 2011, 286, 20710-20726.
172. Wang, X.; Su, B.; Lee, H.G.; Li, X.; Perry, G.; Smith, M.A.; Zhu, X. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J. Neurosci. 2009, 29, 9090-9103.
173. Babior, B.M.; Kipnes, R.S.; Curnutte, J.T. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J. Clin. Invest. 1973, 52, 741-744.
174. 2-producing enzyme of human neutrophils. Further properties. J. Biol. Chem. 1981, 256, 2321-2323.
175. Palmer, R.M.; Ferrige, A.G.; Moncada, S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327, 524-526.
176. Gruetter, C.A.; Barry, B.K.; McNamara, D.B.; Gruetter, D.Y.; Kadowitz, P.J.; Ignarro, L. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J. Cyclic Nucleotide Res. 1979, 5, 211-224.
177. Furchgott, R.F.; Carvalho, M.H.; Khan, M.T.; Matsunaga, K. Evidence for endothelium-dependent vasodilation of resistance vessels by acetylcholine. Blood Vessels 1987, 24, 145-149.
178. Leclercq, B.; Jaimes, E.A.; Raij, L. Nitric oxide synthase and hypertension. Curr. Opin. Nephrol. Hypertens 2002, 11, 185-189.
179. Tabima, D.M.; Frizzell, S.; Gladwin, M.T. Reactive oxygen and nitrogen species in pulmonary hypertension. Free Radic. Biol. Med. 2012, 52, 1970-1986.
180. Tousoulis, D.; Kampoli, A.M.; Tentolouris, C.; Papageorgiou, N.; Stefanadis, C. The role of nitric oxide on endothelial function. Curr. Vasc. Pharmacol. 2012, 10, 4-18.
181. Jaimes, E.A.; Hua, P.; Tian, R.X.; Raij, L. Human glomerular endothelium: Interplay among glucose, free fatty acids, angiotensin II, and oxidative stress. Am. J. Physiol. Renal Physiol. 2010, 298, F125-F132.
182. Radomski, M.W.; Moncada, S. Regulation of vascular homeostasis by nitric oxide. Thromb Haemost 1993, 70, 36-41.
183. Frazziano, G.; Champion, H.C.; Pagano, P.J. NADPH oxidase-derived ROS and the regulation of pulmonary vessel tone. Am. J. Physiol. Heart Circ. Physiol. 2012, 302, H2166-H2177.
184. Satoh, K.; Berk, B.C.; Shimokawa, H. Vascular-derived reactive oxygen species for homeostasis and diseases. Nitric Oxide 2011, 25, 211-215.
185. Erusalimsky, J.D.; Moncada, S. Nitric oxide and mitochondrial signaling: From physiology to pathophysiology. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 2524-2531.
186. Napoli, C.; Ignarro, L.J. Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch. Pharm. Res. 2009, 32, 1103-1108.
187. Zhou, M.S.; Jaimes, E.A.; Raij, L. Vascular but not cardiac remodeling is associated with superoxide production in angiotensin II hypertension. J. Hypertens 2005, 23, 1737-1743.
188. 2 signaling. Antioxid. Redox Signal. 2011, 14, 459-468.
189. Groeger, G.; Quiney, C.; Cotter, T.G. Hydrogen peroxide as a cell-survival signaling molecule. Antioxid. Redox Signal. 2009, 11, 2655-2671.
190. Miller, A.A.; Drummond, G.R.; Sobey, C.G. Reactive oxygen species in the cerebral circulation: Are they all bad? Antioxid. Redox Signal. 2006, 8, 1113-1120.
191. Kamsler, A.; Segal, M. Hydrogen peroxide as a diffusible signal molecule in synaptic plasticity. Mol. NeuroBiol. 2004, 29, 167-178.
192. Kochevar, I.E. Singlet oxygen signaling: From intimate to global. Sci. STKE 2004, 2004, pe7.
193. Turpaev, K.T. Reactive oxygen species and regulation of gene expression. Biochemistry (Mosc.) 2002, 67, 281-292.
194. Kim, P.K.; Zamora, R.; Petrosko, P.; Billiar, T.R. The regulatory role of nitric oxide in apoptosis. Int. Immunopharmacol. 2001, 1, 1421-1441.
195. Martin, L.D.; Krunkosky, T.M.; Voynow, J.A.; Adler, K.B. The role of reactive oxygen and nitrogen species in airway epithelial gene expression. Environ. Health Perspect. 1998, 106, 1197-1203.
196. Ho, J.J.; Man, H.S.; Marsden, P.A. Nitric oxide signaling in hypoxia. J. Mol. Med. (Berl.) 2012, 90, 217-231.
197. Martinez-Ruiz, A.; Cadenas, S.; Lamas, S. Nitric oxide signaling: Classical, less classical, and nonclassical mechanisms. Free Radic. Biol. Med. 2011, 51, 17-29.
198. Bryan, N.S.; Bian, K.; Murad, F. Discovery of the nitric oxide signaling pathway and targets for drug development. Front. Biosci. 2009, 14, 1-18.
199. Afanas'ev, I.B. Signaling functions of free radicals superoxide & nitric oxide under physiological & pathological conditions. Mol. Biotechnol. 2007, 37, 2-4.
200. Buetler, T.M.; Krauskopf, A.; Ruegg, U.T. Role of superoxide as a signaling molecule. News Physiol. Sci. 2004, 19, 120-123.
201. Veal, E.; Day, A. Hydrogen peroxide as a signaling molecule. Antioxid. Redox Signal. 2011, 15, 147-151.
202. Stone, J.R.; Yang, S. Hydrogen peroxide: A signaling messenger. Antioxid. Redox Signal. 2006, 8, 243-270.
203. Rhee, S.G. Redox signaling: Hydrogen peroxide as intracellular messenger. Exp. Mol. Med. 1999, 31, 53-59.
204. Lander, H.M. An essential role for free radicals and derived species in signal transduction. FASEB J. 1997, 11, 118-124.
205. Hensley, K.; Robinson, K.A.; Gabbita, S.P.; Salsman, S.; Floyd, R.A. Reactive oxygen species, cell signaling, and cell injury. Free Radic. Biol. Med. 2000, 28, 1456-1462.
206. Chen, X.L.; Kunsch, C. Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: A new therapeutic approach for the treatment of inflammatory diseases. Curr. Pharm. Des. 2004, 10, 879-891.
207. Itoh, K.; Chiba, T.; Takahashi, S.; Ishii, T.; Igarashi, K.; Katoh, Y.; Oyake, T.; Hayashi, N.; Satoh, K.; Hatayama, I.; et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 1997, 236, 313-322.
208. Thimmulappa, R.K.; Mai, K.H.; Srisuma, S.; Kensler, T.W.; Yamamoto, M.; Biswal, S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 2002, 62, 5196-5203.
209. Chorley, B.N.; Campbell, M.R.; Wang, X.; Karaca, M.; Sambandan, D.; Bangura, F.; Xue, P.; Pi, J.; Kleeberger, S.R.; Bell, D.A. Identification of novel NRF2-regulated genes by ChIP-Seq: Influence on retinoid X receptor alpha. Nucleic Acids Res. 2012, 40, 7416-7429.
210. Taylor, R.C.; Acquaah-Mensah, G.; Singhal, M.; Malhotra, D.; Biswal, S. Network inference algorithms elucidate Nrf2 regulation of mouse lung oxidative stress. PLoS Comput. Biol. 2008, 4, e1000166.
211. Numazawa, S.; Yoshida, T. Nrf2-dependent gene expressions: A molecular toxicological aspect. J. Toxicol. Sci. 2004, 29, 81-89.
212. Reddy, N.M.; Kleeberger, S.R.; Yamamoto, M.; Kensler, T.W.; Scollick, C.; Biswal, S.; Reddy, S.P. Genetic dissection of the Nrf2-dependent redox signaling-regulated transcriptional programs of cell proliferation and cytoprotection. Physiol. Genomics 2007, 32, 74-81.
213. Cheng, X.; Siow, R.C.; Mann, G.E. Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: A role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway. Antioxid. Redox Signal. 2011, 14, 469-487.
214. Van Muiswinkel, F.L.; Kuiperij, H.B. The Nrf2-ARE Signalling pathway: Promising drug target to combat oxidative stress in neurodegenerative disorders. Curr. Drug Targets CNS Neurol. Disord. 2005, 4, 267-281.
215. Kaspar, J.W.; Niture, S.K.; Jaiswal, A.K. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic. Biol. Med. 2009, 47, 1304-1309.
216. Apopa, P.L.; He, X.; Ma, Q. Phosphorylation of Nrf2 in the transcription activation domain by casein kinase 2 (CK2) is critical for the nuclear translocation and transcription activation function of Nrf2 in IMR-32 neuroblastoma cells. J. Biochem. Mol. Toxicol. 2008, 22, 63-76.
217. Numazawa, S.; Ishikawa, M.; Yoshida, A.; Tanaka, S.; Yoshida, T. Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress. Am. J. Physiol. Cell Physiol. 2003, 285, C334-C342.
218. Itoh, K.; Wakabayashi, N.; Katoh, Y.; Ishii, T.; Igarashi, K.; Engel, J.D.; Yamamoto, M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999, 13, 76-86.
219. Dinkova-Kostova, A.T.; Holtzclaw, W.D.; Kensler, T.W. The role of Keap1 in cellular protective responses. Chem. Res. Toxicol. 2005, 18, 1779-1791.
220. Kobayashi, A.; Kang, M.I.; Okawa, H.; Ohtsuji, M.; Zenke, Y.; Chiba, T.; Igarashi, K.; Yamamoto, M. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 2004, 24, 7130-7139.
221. Zhang, D.D.; Lo, S.C.; Cross, J.V.; Templeton, D.J.; Hannink, M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell. Biol. 2004, 24, 10941-10953.
222. Zhang, D.D. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev. 2006, 38, 769-789.
223. Tong, K.I.; Kobayashi, A.; Katsuoka, F.; Yamamoto, M. Two-site substrate recognition model for the Keap1-Nrf2 system: A hinge and latch mechanism. Biol. Chem. 2006, 387, 1311-1320.
224. Kensler, T.W.; Wakabayashi, N.; Biswal, S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 2007, 47, 89-116.
225. Villeneuve, N.F.; Lau, A.; Zhang, D.D. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: An insight into cullin-ring ubiquitin ligases. Antioxid. Redox Signal. 2010, 13, 1699-1712.
226. Itoh, K.; Mimura, J.; Yamamoto, M. Discovery of the negative regulator of Nrf2, Keap1: A historical overview. Antioxid. Redox Signal. 2010, 13, 1665-1678.
227. Baird, L.; Dinkova-Kostova, A.T. The cytoprotective role of the Keap1-Nrf2 pathway. Arch. Toxicol. 2011, 85, 241-272.
228. Tkachev, V.O.; Menshchikova, E.B.; Zenkov, N.K. Mechanism of the Nrf2/Keap1/ARE signaling system. Biochemistry (Mosc.) 2011, 76, 407-422.
229. Dhakshinamoorthy, S.; Porter, A.G. Nitric oxide-induced transcriptional up-regulation of protective genes by Nrf2 via the antioxidant response element counteracts apoptosis of neuroblastoma cells. J. Biol. Chem. 2004, 279, 20096-20107.
230. 2 via an antioxidant response element. FASEB J. 2005, 19, 2085-2087.
231. Ashino, T.; Yamanaka, R.; Yamamoto, M.; Shimokawa, H.; Sekikawa, K.; Iwakura, Y.; Shioda, S.; Numazawa, S.; Yoshida, T. Negative feedback regulation of lipopolysaccharide-induced inducible nitric oxide synthase gene expression by heme oxygenase-1 induction in macrophages. Mol. Immunol. 2008, 45, 2106-2115.
232. Buckley, B.J.; Marshall, Z.M.; Whorton, A.R. Nitric oxide stimulates Nrf2 nuclear translocation in vascular endothelium. Biochem. Biophys. Res. Commun. 2003, 307, 973-979.
233. Fourquet, S.; Guerois, R.; Biard, D.; Toledano, M.B. Activation of NRF2 by nitrosative agents and H2O2 involves KEAP1 disulfide formation. J. Biol. Chem. 2010, 285, 8463-8471.
234. Motohashi, H.; Yamamoto, M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 2004, 10, 549-557.
235. Sen, R.; Baltimore, D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986, 46, 705-716.
236. Ghosh, S.; May, M.J.; Kopp, E.B. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998, 16, 225-260.
237. Farrow, S.N. Death receptors, NF-kappa B activation and apoptosis: The potential for therapeutic intervention. Biochem. Soc. Trans. 1999, 27, 812-814.
238. Van Antwerp, D.J.; Martin, S.J.; Verma, I.M.; Green, D.R. Inhibition of TNF-induced apoptosis by NF-kappa B. Trends Cell Biol. 1998, 8, 107-111.
239. Sonenshein, G.E. Rel/NF-kappa B transcription factors and the control of apoptosis. Semin. Cancer Biol. 1997, 8, 113-119.
240. Francis, D.A.; Sen, R.; Rothstein, T.L. Receptor-specific regulation of NF-kappa B, c-Myc and Fas-mediated apoptosis in primary B cells. Curr. Top. MicroBiol. Immunol. 1997, 224, 83-90.
241. Wang, H.; Cho, C.H. Effect of NF-kappaB signaling on apoptosis in chronic inflammation-associated carcinogenesis. Curr. Cancer Drug Targets 2010, 10, 593-599.
242. Piotrowska, A.; Izykowska, I.; Podhorska-Okolow, M.; Zabel, M.; Dziegiel, P. The structure of NF-kappaB family proteins and their role in apoptosis. Postepy Hig. Med. Dosw. (Online) 2008, 62, 64-74.
243. Sen, R. Control of B lymphocyte apoptosis by the transcription factor NF-kappaB. Immunity 2006, 25, 871-883.
244. Kucharczak, J.; Simmons, M.J.; Fan, Y.; Gelinas, C. To be, or not to be: NF-kappaB is the answer-Role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 2003, 22, 8961-8982.
245. Barkett, M.; Gilmore, T.D. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 1999, 18, 6910-6924.
246. DiDonato, J.A.; Mercurio, F.; Karin, M. NF-kappaB and the link between inflammation and cancer. Immunol. Rev. 2012, 246, 379-400.
247. Ben-Neriah, Y.; Karin, M. Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat. Immunol. 2011, 12, 715-723.
248. Baker, R.G.; Hayden, M.S.; Ghosh, S. NF-kappaB, inflammation, and metabolic disease. Cell Metab. 2011, 13, 11-22.
249. Sanz, A.B.; Sanchez-Nino, M.D.; Ramos, A.M.; Moreno, J.A.; Santamaria, B.; Ruiz-Ortega, M.; Egido, J.; Ortiz, A. NF-kappaB in renal inflammation. J. Am. Soc. Nephrol. 2010, 21, 1254-1262.
250. Lawrence, T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb. Perspect. Biol. 2009, 1, a001651.
251. Lawrence, T.; Fong, C. The resolution of inflammation: Anti-inflammatory roles for NF-kappaB. Int. J. Biochem. Cell Biol. 2010, 42, 519-523.
252. Gerondakis, S.; Grumont, R.; Gugasyan, R.; Wong, L.; Isomura, I.; Ho, W.; Banerjee, A. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene 2006, 25, 6781-6799.
253. Monaco, C.; Andreakos, E.; Kiriakidis, S.; Mauri, C.; Bicknell, C.; Foxwell, B.; Cheshire, N.; Paleolog, E.; Feldmann, M. Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. Proc. Natl. Acad. Sci. USA 2004, 101, 5634-5639.
254. Song, X.Q.; Lv, L.X.; Li, W.Q.; Hao, Y.H.; Zhao, J.P. The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia. Biol. Psychiatry 2009, 65, 481-488.
255. Yamamoto, Y.; Gaynor, R.B. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 2001, 107, 135-142.
256. Yamamoto, Y.; Gaynor, R.B. Role of the NF-kappaB pathway in the pathogenesis of human disease states. Curr. Mol. Med. 2001, 1, 287-296.
257. Hoffmann, A.; Natoli, G.; Ghosh, G. Transcriptional regulation via the NF-kappaB signaling module. Oncogene 2006, 25, 6706-6716.
258. Yamamoto, Y.; Gaynor, R.B. IkappaB kinases: Key regulators of the NF-kappaB pathway. Trends Biochem. Sci. 2004, 29, 72-79.
259. Hansen, S.K.; Guerrini, L.; Blasi, F. Differential DNA sequence specificity and regulation of HIV-1 enhancer activity by cRel-RelA transcription factor. J. Biol. Chem. 1994, 269, 22230-22237.
260. Brown, A.M.; Linhoff, M.W.; Stein, B.; Wright, K.L.; Baldwin, A.S., Jr.; Basta, P.V.; Ting, J.P. Function of NF-kappa B/Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-kappa B/Rel subunits. Mol. Cell Biol. 1994, 14, 2926-2935.
261. Plaksin, D.; Baeuerle, P.A.; Eisenbach, L. KBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells. J. Exp. Med. 1993, 177, 1651-1662.
262. Kone, B.C.; Schwobel, J.; Turner, P.; Mohaupt, M.G.; Cangro, C.B. Role of NF-kappa B in the regulation of inducible nitric oxide synthase in an MTAL cell line. Am. J. Physiol. 1995, 269, F718-F729.
263. Pahan, K.; Sheikh, F.G.; Liu, X.; Hilger, S.; McKinney, M.; Petro, T.M. Induction of nitric-oxide synthase and activation of NF-kappaB by interleukin-12 p40 in microglial cells. J. Biol. Chem. 2001, 276, 7899-7905.
264. Fouad, D.; Siendones, E.; Costan, G.; Muntane, J. Role of NF-kappaB activation and nitric oxide expression during PGE protection against d-galactosamine-induced cell death in cultured rat hepatocytes. Liver Int. 2004, 24, 227-236.
265. Griscavage, J.M.; Wilk, S.; Ignarro, L.J. Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B. Proc. Natl. Acad. Sci. USA 1996, 93, 3308-3312.
266. Lee, K.M.; Kang, B.S.; Lee, H.L.; Son, S.J.; Hwang, S.H.; Kim, D.S.; Park, J.S.; Cho, H.J. Spinal NF-kB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity. Eur. J. NeuroSci. 2004, 19, 3375-3381.
267. Schmedtje, J.F., Jr.; Ji, Y.S.; Liu, W.L.; DuBois, R.N.; Runge, M.S. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J. Biol. Chem. 1997, 272, 601-608.
268. Jobin, C.; Morteau, O.; Han, D.S.; Balfour Sartor, R. Specific NF-kappaB blockade selectively inhibits tumour necrosis factor-alpha-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells. Immunology 1998, 95, 537-543.
269. Schreck, R.; Rieber, P.; Baeuerle, P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 1991, 10, 2247-2258.
270. Schreck, R.; Meier, B.; Mannel, D.N.; Droge, W.; Baeuerle, P.A. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp. Med. 1992, 175, 1181-1194.
271. Schreck, R.; Grassmann, R.; Fleckenstein, B.; Baeuerle, P.A. Antioxidants selectively suppress activation of NF-kappa B by human T-cell leukemia virus type I Tax protein. J. Virol 1992, 66, 6288-6293.
272. Lander, H.M.; Sehajpal, P.; Levine, D.M.; Novogrodsky, A. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 1993, 150, 1509-1516.
273. Shibanuma, M.; Kuroki, T.; Nose, K. Inhibition by N-acetyl-L-cysteine of interleukin-6 mRNA induction and activation of NF kappa B by tumor necrosis factor alpha in a mouse fibroblastic cell line, Balb/3T3. FEBS Lett. 1994, 353, 62-66.
274. Manna, S.K.; Zhang, H.J.; Yan, T.; Oberley, L.W.; Aggarwal, B.B. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J. Biol. Chem. 1998, 273, 13245-13254.
275. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 1993, 12, 2005-2015.
276. Kim, S.J.; Hwang, S.G.; Shin, D.Y.; Kang, S.S.; Chun, J.S. p38 kinase regulates nitric oxide-induced apoptosis of articular chondrocytes by accumulating p53 via NFkappa B-dependent transcription and stabilization by serine 15 phosphorylation. J. Biol. Chem. 2002, 277, 33501-33508.
277. Lee, S.; Chung, J.; Ha, I.S.; Yi, K.; Lee, J.E.; Kang, H.G.; Choi, I.; Oh, K.H.; Kim, J.Y.; Surh, C.D.; et al. Hydrogen peroxide increases human leukocyte adhesion to porcine aortic endothelial cells via NFkappaB-dependent up-regulation of VCAM-1. Int. Immunol. 2007, 19, 1349-1359.
278. Zhang, J.; Johnston, G.; Stebler, B.; Keller, E.T. Hydrogen peroxide activates NFkappaB and the interleukin-6 promoter through NFkappaB-inducing kinase. Antioxid. Redox Signal. 2001, 3, 493-504.
279. Waldow, T.; Witt, W.; Weber, E.; Matschke, K. Nitric oxide donor-induced persistent inhibition of cell adhesion protein expression and NFkappaB activation in endothelial cells. Nitric Oxide 2006, 15, 103-113.
280. Nam, H.Y.; Choi, B.H.; Lee, J.Y.; Lee, S.G.; Kim, Y.H.; Lee, K.H.; Yoon, H.K.; Song, J.S.; Kim, H.J.; Lim, Y. The role of nitric oxide in the particulate matter (PM2.5)-induced NFkappaB activation in lung epithelial cells. Toxicol. Lett. 2004, 148, 95-102.
281. Tsai, S.H.; Lin-Shiau, S.Y.; Lin, J.K. Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br. J. Pharmacol. 1999, 126, 673-680.
282. Schreck, R.; Albermann, K.; Baeuerle, P.A. Nuclear factor kappa B: An oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic. Res. Commun. 1992, 17, 221-237.
283. Packer, L.; Suzuki, Y.J. Vitamin E and alpha-lipoate: Role in antioxidant recycling and activation of the NF-kappa B transcription factor. Mol. Aspects Med. 1993, 14, 229-239.
284. Suzuki, Y.J.; Packer, L. Inhibition of NF-kappa B DNA binding activity by alpha-tocopheryl succinate. Biochem. Mol. Biol. Int. 1993, 31, 693-700.
285. Kretz-Remy, C.; Mehlen, P.; Mirault, M.E.; Arrigo, A.P. Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression. J. Cell Biol. 1996, 133, 1083-1093.
286. Aravindan, N.; Mohan, S.; Herman, T.S.; Natarajan, M. Nitric oxide-mediated inhibition of NFkappaB regulates hyperthermia-induced apoptosis. J. Cell Biochem. 2009, 106, 999-1009.
287. Gilad, E.; Wong, H.R.; Zingarelli, B.; Virag, L.; O'Connor, M.; Salzman, A.L.; Szabo, C. Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: Role of inhibition of NFkappaB activation. FASEB J. 1998, 12, 685-693.
288. Matthews, J.R.; Botting, C.H.; Panico, M.; Morris, H.R.; Hay, R.T. Inhibition of NF-kappaB DNA binding by nitric oxide. Nucleic Acids Res. 1996, 24, 2236-2242.
289. Peng, H.B.; Libby, P.; Liao, J.K. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J. Biol. Chem. 1995, 270, 14214-14219.
290. Taylor, B.S.; Kim, Y.M.; Wang, Q.; Shapiro, R.A.; Billiar, T.R.; Geller, D.A. Nitric oxide down-regulates hepatocyte-inducible nitric oxide synthase gene expression. Arch. Surg. 1997, 132, 1177-1183.
291. Sekkai, D.; Aillet, F.; Israel, N.; Lepoivre, M. Inhibition of NF-kappaB and HIV-1 long terminal repeat transcriptional activation by inducible nitric oxide synthase 2 activity. J. Biol. Chem. 1998, 273, 3895-3900.
292. Ohkita, M.; Takaoka, M.; Shiota, Y.; Nojiri, R.; Matsumura, Y. Nitric oxide inhibits endothelin-1 production through the suppression of nuclear factor kappa B. Clin. Sci. (Lond.) 2002, 103, 68S-71S.
293. Perkins, N.D.; Gilmore, T.D. Good cop, bad cop: The different faces of NF-kappaB. Cell Death Differ. 2006, 13, 759-772.
294. Xie, Q.W.; Kashiwabara, Y.; Nathan, C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 1994, 269, 4705-4708.
295. Muhl, H.; Pfeilschifter, J. Amplification of nitric oxide synthase expression by nitric oxide in interleukin 1 beta-stimulated rat mesangial cells. J. Clin. Invest. 1995, 95, 1941-1946.
296. Zouki, C.; Jozsef, L.; Ouellet, S.; Paquette, Y.; Filep, J.G. Peroxynitrite mediates cytokine-induced IL-8 gene expression and production by human leukocytes. J. Leukoc Biol. 2001, 69, 815-824.
297. Colasanti, M.; Persichini, T.; Menegazzi, M.; Mariotto, S.; Giordano, E.; Caldarera, C.M.; Sogos, V.; Lauro, G.M.; Suzuki, H. Induction of nitric oxide synthase mRNA expression. Suppression by exogenous nitric oxide. J. Biol. Chem. 1995, 270, 26731-26733.
298. Park, S.K.; Lin, H.L.; Murphy, S. Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-kappaB binding to DNA. Biochem. J. 1997, 322, 609-613.
299. Chen, F.; Lu, Y.; Castranova, V.; Rojanasakul, Y.; Miyahara, K.; Shizuta, Y.; Vallyathan, V.; Shi, X.; Demers, L.M. Nitric oxide inhibits HIV tat-induced NF-kappaB activation. Am. J. Pathol. 1999, 155, 275-284.
300. Matthews, J.R.; Wakasugi, N.; Virelizier, J.L.; Yodoi, J.; Hay, R.T. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res. 1992, 20, 3821-3830.
301. Mitomo, K.; Nakayama, K.; Fujimoto, K.; Sun, X.; Seki, S.; Yamamoto, K. Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-kappa B in vitro. Gene 1994, 145, 197-203.
302. Satriano, J.; Schlondorff, D. Activation and attenuation of transcription factor NF-κB in mouse glomerular mesangial cells in response to tumor necrosis factor-alpha, immunoglobulin G, and adenosine 3':5'-cyclic monophosphate. Evidence for involvement of reactive oxygen species. J. Clin. Invest. 1994, 94, 1629-1636.
303. Schreck, R.; Baeuerle, P.A. Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-kappa B. Methods Enzymol. 1994, 234, 151-163.
304. Kabe, Y.; Ando, K.; Hirao, S.; Yoshida, M.; Handa, H. Redox regulation of NF-kappaB activation: Distinct redox regulation between the cytoplasm and the nucleus. Antioxid. Redox Signal. 2005, 7, 395-403.
305. Nishi, T.; Shimizu, N.; Hiramoto, M.; Sato, I.; Yamaguchi, Y.; Hasegawa, M.; Aizawa, S.; Tanaka, H.; Kataoka, K.; Watanabe, H.; et al. Spatial redox regulation of a critical cysteine residue of NF-kappa B in vivo. J. Biol. Chem. 2002, 277, 44548-44556.
306. Toledano, M.B.; Leonard, W.J. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. USA 1991, 88, 4328-4332.
307. Pineda-Molina, E.; Klatt, P.; Vazquez, J.; Marina, A.; Garcia de Lacoba, M.; Perez-Sala, D.; Lamas, S. Glutathionylation of the p50 subunit of NF-kappaB: A mechanism for redox-induced inhibition of DNA binding. Biochemistry 2001, 40, 14134-14142.
308. Kamata, H.; Manabe, T.; Oka, S.; Kamata, K.; Hirata, H. Hydrogen peroxide activates IkappaB kinases through phosphorylation of serine residues in the activation loops. FEBS Lett. 2002, 519, 231-237.
309. Vandermoere, F.; El Yazidi-Belkoura, I.; Adriaenssens, E.; Lemoine, J.; Hondermarck, H. The antiapoptotic effect of fibroblast growth factor-2 is mediated through nuclear factor-kappaB activation induced via interaction between Akt and IkappaB kinase-beta in breast cancer cells. Oncogene 2005, 24, 5482-5491.
310. Jamaluddin, M.; Wang, S.; Boldogh, I.; Tian, B.; Brasier, A.R. TNF-alpha-induced NF-kappaB/RelA Ser(276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway. Cell Signal. 2007, 19, 1419-1433.
311. 2-dependent activation of GCLC-ARE4 reporter occurs by mitogen-activated protein kinase pathways without oxidation of cellular glutathione or thioredoxin-1. J. Biol. Chem. 2004, 279, 5837-5845.
312. 2 on the receptor tyrosine kinases, the MAP kinase cascade, and IkappaB kinases. Ann. N. Y. Acad. Sci. 2002, 973, 419-422.
313. Vayalil, P.K.; Iles, K.E.; Choi, J.; Yi, A.K.; Postlethwait, E.M.; Liu, R.M. Glutathione suppresses TGF-beta-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter. Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 293, L1281-L1292.
314. Finocchietto, P.V.; Franco, M.C.; Holod, S.; Gonzalez, A.S.; Converso, D.P.; Antico Arciuch, V.G.; Serra, M.P.; Poderoso, J.J.; Carreras, M.C. Mitochondrial nitric oxide synthase: A masterpiece of metabolic adaptation, cell growth, transformation, and death. Exp. Biol. Med. (Maywood) 2009, 234, 1020-1028.
315. Carreras, M.C.; Poderoso, J.J. Mitochondrial nitric oxide in the signaling of cell integrated responses. Am. J. Physiol. Cell Physiol. 2007, 292, C1569-C1580.
316. Gorlach, A.; Diebold, I.; Schini-Kerth, V.B.; Berchner-Pfannschmidt, U.; Roth, U.; Brandes, R.P.; Kietzmann, T.; Busse, R. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase. Circ. Res. 2001, 89, 47-54.
317. Shatrov, V.A.; Sumbayev, V.V.; Zhou, J.; Brune, B. Oxidized low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1alpha (HIF-1alpha) accumulation via redox-dependent mechanisms. Blood 2003, 101, 4847-4849.
318. Li, C.Q.; Robles, A.I.; Hanigan, C.L.; Hofseth, L.J.; Trudel, L.J.; Harris, C.C.; Wogan, G.N. Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53. Cancer Res. 2004, 64, 3022-3029.
319. Rainwater, R.; Parks, D.; Anderson, M.E.; Tegtmeyer, P.; Mann, K. Role of cysteine residues in regulation of p53 function. Mol. Cell Biol. 1995, 15, 3892-3903.
320. Yang, F.; von Knethen, A.; Brune, B. Modulation of nitric oxide-evoked apoptosis by the p53-downstream target p21(WAF1/CIP1). J. Leukoc. Biol. 2000, 68, 916-922.
321. Giaccia, A.J.; Kastan, M.B. The complexity of p53 modulation: Emerging patterns from divergent signals. Genes Dev. 1998, 12, 2973-2983.
322. Li, J.M.; Fan, L.M.; George, V.T.; Brooks, G. Nox2 regulates endothelial cell cycle arrest and apoptosis via p21cip1 and p53. Free Radic. Biol. Med. 2007, 43, 976-986.
323. Liu, B.; Chen, Y.; St Clair, D.K. ROS and p53: A versatile partnership. Free Radic. Biol. Med. 2008, 44, 1529-1535.
324. Sun, Y.; Oberley, L.W. Redox regulation of transcriptional activators. Free Radic. Biol. Med. 1996, 21, 335-348.
325. Roebuck, K.A. Oxidant stress regulation of IL-8 and ICAM-1 gene expression: Differential activation and binding of the transcription factors AP-1 and NF-kappaB (Review). Int. J. Mol. Med. 1999, 4, 223-230.
326. Wu, X.; Bishopric, N.H.; Discher, D.J.; Murphy, B.J.; Webster, K.A. Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol. Cell. Biol. 1996, 16, 1035-1046.
327. Akiba, S.; Chiba, M.; Mukaida, Y.; Sato, T. Involvement of reactive oxygen species and SP-1 in fibronectin production by oxidized LDL. Biochem. Biophys. Res. Commun. 2003, 310, 491-497.
328. Hampton, M.B.; Orrenius, S. Dual regulation of caspase activity by hydrogen peroxide: Implications for apoptosis. FEBS Lett. 1997, 414, 552-556.
329. Higuchi, M.; Honda, T.; Proske, R.J.; Yeh, E.T. Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases. Oncogene 1998, 17, 2753-2760.
330. Moungjaroen, J.; Nimmannit, U.; Callery, P.S.; Wang, L.; Azad, N.; Lipipun, V.; Chanvorachote, P.; Rojanasakul, Y. Reactive oxygen species mediate caspase activation and apoptosis induced by lipoic acid in human lung epithelial cancer cells through Bcl-2 down-regulation. J. Pharmacol. Exp. Ther. 2006, 319, 1062-1069.
331. Fadeel, B.; Ahlin, A.; Henter, J.I.; Orrenius, S.; Hampton, M.B. Involvement of caspases in neutrophil apoptosis: Regulation by reactive oxygen species. Blood 1998, 92, 4808-4818.
332. Izeradjene, K.; Douglas, L.; Tillman, D.M.; Delaney, A.B.; Houghton, J.A. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines. Cancer Res. 2005, 65, 7436-7445.
333. Vlahopoulos, S.; Boldogh, I.; Casola, A.; Brasier, A.R. Nuclear factor-kappaB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: Evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation. Blood 1999, 94, 1878-1889.
334. Kurdi, M.; Booz, G.W. Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: Parthenolide targets JAK1 activation by generating ROS. J. Cell Physiol. 2007, 212, 424-431.
335. Schulze-Osthoff, K.; Beyaert, R.; Vandevoorde, V.; Haegeman, G.; Fiers, W. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 1993, 12, 3095-3104.
336. De Keulenaer, G.W.; Ushio-Fukai, M.; Yin, Q.; Chung, A.B.; Lyons, P.R.; Ishizaka, N.; Rengarajan, K.; Taylor, W.R.; Alexander, R.W.; Griendling, K.K. Convergence of redox-sensitive and mitogen-activated protein kinase signaling pathways in tumor necrosis factor-alpha-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2000, 20, 385-391.
337. Shimada, T.; Watanabe, N.; Hiraishi, H.; Terano, A. Redox regulation of interleukin-8 expression in MKN28 cells. Dig. Dis. Sci. 1999, 44, 266-273.
338. Lo, Y.Y.; Cruz, T.F. Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J. Biol. Chem. 1995, 270, 11727-11730.
339. Maulik, N.; Das, D.K. Redox signaling in vascular angiogenesis. Free Radic. Biol. Med. 2002, 33, 1047-1060.
340. Eyries, M.; Collins, T.; Khachigian, L.M. Modulation of growth factor gene expression in vascular cells by oxidative stress. Endothelium 2004, 11, 133-139.
341. 2 for platelet-derived growth factor signal transduction. Science 1995, 270, 296-299.
342. Morgan, M.J.; Liu, Z.G. Reactive oxygen species in TNFalpha-induced signaling and cell death. Mol. Cells 2010, 30, 1-12.
343. Circu, M.L.; Aw, T.Y. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic. Biol. Med. 2010, 48, 749-762.
344. Fruehauf, J.P.; Meyskens, F.L., Jr. Reactive oxygen species: A breath of life or death? Clin. Cancer Res. 2007, 13, 789-794.
345. Simon, H.U.; Haj-Yehia, A.; Levi-Schaffer, F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 2000, 5, 415-418.
346. Kizaki, M.; Xian, M.; Sagawa, M.; Ikeda, Y. Induction of apoptosis via the modulation of reactive oxygen species (ROS) production in the treatment of myeloid leukemia. Curr. Pharm. Biotechnol. 2006, 7, 323-329.
347. Leon, L.; Jeannin, J.F.; Bettaieb, A. Post-translational modifications induced by nitric oxide (NO): Implication in cancer cells apoptosis. Nitric. Oxide 2008, 19, 77-83.
348. Tarr, J.M.; Eggleton, P.; Winyard, P.G. Nitric oxide and the regulation of apoptosis in tumour cells. Curr. Pharm. Des. 2006, 12, 4445-4468.
349. Li, C.Q.; Wogan, G.N. Nitric oxide as a modulator of apoptosis. Cancer Lett. 2005, 226, 1-15.
350. Brune, B. The intimate relation between nitric oxide and superoxide in apoptosis and cell survival. Antioxid. Redox Signal. 2005, 7, 497-507.
351. Vieira, H.; Kroemer, G. Mitochondria as targets of apoptosis regulation by nitric oxide. IUBMB Life 2003, 55, 613-616.
352. Brune, B.; Zhou, J.; von Knethen, A. Nitric oxide, oxidative stress, and apoptosis. Kidney Int. Suppl. 2003, S22-S24.
353. Park, J.B. Phagocytosis induces superoxide formation and apoptosis in macrophages. Exp. Mol. Med. 2003, 35, 325-335.
354. Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M.T.; Mazur, M.; Telser, J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39, 44-84.
355. Ghosh, N.; Ghosh, R.; Mandal, S.C. Antioxidant protection: A promising therapeutic intervention in neurodegenerative disease. Free Radic. Res. 2011, 45, 888-905.
356. Iborra, M.; Moret, I.; Rausell, F.; Bastida, G.; Aguas, M.; Cerrillo, E.; Nos, P.; Beltran, B. Role of oxidative stress and antioxidant enzymes in Crohn's disease. Biochem. Soc. Trans. 2011, 39, 1102-1106.
357. Dumont, M.; Lin, M.T.; Beal, M.F. Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease. J. Alzheimers Dis. 2010, 20, S633-S643.
358. De Vries, H.E.; Witte, M.; Hondius, D.; Rozemuller, A.J.; Drukarch, B.; Hoozemans, J.; van Horssen, J. Nrf2-induced antioxidant protection: A promising target to counteract ROS-mediated damage in neurodegenerative disease? Free Radic. Biol. Med. 2008, 45, 1375-1383.
359. De Araujo, D.P.; Lobato Rde, F.; Cavalcanti, J.R.; Sampaio, L.R.; Araujo, P.V.; Silva, M.C.; Neves, K.R.; Fonteles, M.M.; Sousa, F.C.; Vasconcelos, S.M. The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson's disease: A review. Int. J. NeuroSci. 2011, 121, 51-57.
360. Aliev, G.; Obrenovich, M.E.; Reddy, V.P.; Shenk, J.C.; Moreira, P.I.; Nunomura, A.; Zhu, X.; Smith, M.A.; Perry, G. Antioxidant therapy in Alzheimer's disease: Theory and practice. Mini Rev. Med. Chem. 2008, 8, 1395-1406.
361. Zarjou, A.; Sanders, P.W.; Mehta, R.L.; Agarwal, A. Enabling innovative translational research in acute kidney injury. Clin. Transl. Sci. 2012, 5, 93-101.
362. Aziz, M.H.; Kumar, R.; Ahmad, N. Cancer chemoprevention by resveratrol: In vitro and in vivo studies and the underlying mechanisms (review). Int. J. Oncol. 2003, 23, 17-28.
363. Turan, B.; Vassort, G. Vitamin E in oxidant stress-related cardiovascular pathologies: Focus on experimental studies. Curr. Pharm. Des. 2011, 17, 2155-2169.
364. Turan, B. Role of antioxidants in redox regulation of diabetic cardiovascular complications. Curr. Pharm. Biotechnol. 2010, 11, 819-836.
365. Violi, F.; Cangemi, R. Antioxidants and cardiovascular disease. Curr. Opin. Investig Drugs 2005, 6, 895-900.
366. Maxwell, S.R.; Lip, G.Y. Free radicals and antioxidants in cardiovascular disease. Br. J. Clin. Pharmacol. 1997, 44, 307-317.
367. Tylicki, L.; Rutkowski, B.; Horl, W.H. Antioxidants: A possible role in kidney protection. Kidney Blood Press Res. 2003, 26, 303-314.
368. Day, B.J. Antioxidants as potential therapeutics for lung fibrosis. Antioxid. Redox Signal. 2008, 10, 355-370.
369. Kinnula, V.L.; Crapo, J.D. Superoxide dismutases in the lung and human lung diseases. Am. J. Respir Crit. Care Med. 2003, 167, 1600-1619.
370. Russell, G.A. Antioxidants and neonatal lung disease. Eur. J. Pediatr. 1994, 153, S36-S41.
371. Kamat, C.D.; Gadal, S.; Mhatre, M.; Williamson, K.S.; Pye, Q.N.; Hensley, K. Antioxidants in central nervous system diseases: Preclinical promise and translational challenges. J. Alzheimers Dis. 2008, 15, 473-493.
372. Durante, W. Targeting heme oxygenase-1 in vascular disease. Curr. Drug Targets 2010, 11, 1504-1516.
373. Subramanian, S.; Kalyanaraman, B.; Migrino, R.Q. Mitochondrially targeted antioxidants for the treatment of cardiovascular diseases. Recent Pat. Cardiovasc. Drug Discov. 2010, 5, 54-65.
374. Sawyer, D.B. Oxidative stress in heart failure: What are we missing? Am. J. Med. Sci. 2011, 342, 120-124.
375. Wu, J.; Hecker, J.G.; Chiamvimonvat, N. Antioxidant enzyme gene transfer for ischemic diseases. Adv. Drug Deliv. Rev. 2009, 61, 351-363.
376. Golden, T.R.; Patel, M. Catalytic antioxidants and neurodegeneration. Antioxid. Redox Signal. 2009, 11, 555-570.
377. Poljsak, B.; Milisav, I. The neglected significance of "antioxidative stress". Oxid. Med. Cell Longev. 2012, 2012, 480895.
378. Firuzi, O.; Miri, R.; Tavakkoli, M.; Saso, L. Antioxidant therapy: Current status and future prospects. Curr. Med. Chem. 2011, 18, 3871-3888.
379. Mecocci, P.; Polidori, M.C. Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease. Biochim. Biophys. Acta 2012, 1822, 631-638.
380. Shamseer, L.; Adams, D.; Brown, N.; Johnson, J.A.; Vohra, S. Antioxidant micronutrients for lung disease in cystic fibrosis. Cochrane Database Syst. Rev. 2010, doi:10.1002/14651858.CD007020.pub2.
381. Nunez-Cordoba, J.M.; Martinez-Gonzalez, M.A. Antioxidant vitamins and cardiovascular disease. Curr. Top. Med. Chem. 2011, 11, 1861-1869.
382. Bonnefont-Rousselot, D.; Collin, F. Melatonin: Action as antioxidant and potential applications in human disease and aging. Toxicology 2010, 278, 55-67.
383. Lee, H.P.; Zhu, X.; Casadesus, G.; Castellani, R.J.; Nunomura, A.; Smith, M.A.; Lee, H.G.; Perry, G. Antioxidant approaches for the treatment of Alzheimer's disease. Expert Rev. Neurother. 2010, 10, 1201-1208.
384. Farbstein, D.; Kozak-Blickstein, A.; Levy, A.P. Antioxidant vitamins and their use in preventing cardiovascular disease. Molecules 2010, 15, 8098-8110.
385. Levonen, A.L.; Vahakangas, E.; Koponen, J.K.; Yla-Herttuala, S. Antioxidant gene therapy for cardiovascular disease: Current status and future perspectives. Circulation 2008, 117, 2142-2150.
386. Davis, C.A.; Nick, H.S.; Agarwal, A. Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: Importance of superoxide. J. Am. Soc. Nephrol. 2001, 12, 2683-2690.